Related references
Note: Only part of the references are listed.Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study
Tao Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Clinicopathological Outcomes and Prognosis of Elderly Patients (65Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review
Zifeng Yang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2019)
Systematic review of current prognostication systems for primary gastrointestinal stromal tumors
Chun Yuet Khoo et al.
EJSO (2018)
Soft Tissue Sarcoma, Version 2.2018
Margaret von Mehren et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients
Sheima Farag et al.
EUROPEAN JOURNAL OF CANCER (2017)
Management of Gastrointestinal Stromal Tumors
Emily Z. Keung et al.
SURGICAL CLINICS OF NORTH AMERICA (2017)
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
Toshirou Nishida et al.
GASTRIC CANCER (2016)
Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients
Aik-Yong Chok et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis
Danielle A. Bischof et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Gastrointestinal Stromal Tumors: Treatment Patterns of a Population-Based Sample
Linda C. Harlan et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection
Annie Guerin et al.
JAMA ONCOLOGY (2015)
The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy
Annie Guerin et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized Trial
Heikki Joensuu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States
Myrlene Sanon et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
Aurore Blesius et al.
BMC CANCER (2011)
Rare Incidence of Congestive Heart Failure in Gastrointestinal Stromal Tumor and Other Sarcoma Patients Receiving Imatinib Mesylate
Jonathan C. Trent et al.
CANCER (2010)
Budgetary Impact of Treatment with Adjuvant Imatinib for 1 Year Following Surgical Resection of Kit-Positive Localized Gastrointestinal Stromal Tumors
Jaime L. Rubin et al.
JOURNAL OF MANAGED CARE PHARMACY (2010)
A Randomized, Phase II Study of Preoperative plus Postoperative Imatinib in GIST: Evidence of Rapid Radiographic Response and Temporal Induction of Tumor Cell Apoptosis
John C. McAuliffe et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
M. Fiore et al.
EJSO (2009)
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P. DeMatteo et al.
LANCET (2009)
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
Jason S. Gold et al.
LANCET ONCOLOGY (2009)
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
Markku Miettinen et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2006)
Indications for imatinib mesylate therapy and clinical management
F Guilhot
ONCOLOGIST (2004)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Diagnosis of gastrointestinal stromal tumors: A consensus approach
CDM Fletcher et al.
HUMAN PATHOLOGY (2002)
Share Paper
